• Breast Cancer: Oral SERDs in ER+ breast cancer. Episode 2 - treatment selection and beyond

  • Jul 26 2023
  • Duración: 25 m
  • Podcast

Breast Cancer: Oral SERDs in ER+ breast cancer. Episode 2 - treatment selection and beyond

  • Resumen

  • COR2ED Medical Education: In this podcast, the experts deep-dive into two patient case studies of ER+/HER2- metastatic breast cancer, discussing the intricacies of treatment selection and sequencing to maximise outcomes, current data, and what to consider when adjusting dosage or switching treatments.

    Dr. Rena Callahan an Associate Clinical Professor of Hematology Oncology at University of California, Los Angeles David Geffen School of Medicine and Dr. Shaheenah Dawood, a consultant medical oncologist and professor of oncology at Mediclinic City Hospital, United Arab Emirates, Dubai discuss oral SERDs, a novel therapy for ER+/HER2- advanced or metastatic breast cancer.

    Más Menos
activate_Holiday_promo_in_buybox_DT_T2

Lo que los oyentes dicen sobre Breast Cancer: Oral SERDs in ER+ breast cancer. Episode 2 - treatment selection and beyond

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.